AG
LRMR icon

Algert Global’s Larimar Therapeutics LRMR Stock Holding History

Algert Global’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,030
Closed -$84K – 1253
2025
Q2 		$84K Buy
29,030
+5,750
+25% +$13.3K ﹤0.01% 1145
2025
Q1 		$50K Buy
23,280
+11,090
+91% +$35.1K ﹤0.01% 1153
2024
Q4 		$47K Buy
+12,190
New +$80.5K ﹤0.01% 1146
2019
Q1 		– Sell
-5,425
Closed -$322K – 356
2018
Q4 		$322K Sell
5,425
-738
-12% -$72.9K 0.09% 271
2018
Q3 		$865K Buy
6,163
+4,574
+288% +$555K 0.19% 190
2018
Q2 		$195K Sell
1,589
-587
-27% -$49.9K 0.04% 314
2018
Q1 		$195K Buy
+2,176
New +$184K 0.04% 310
2017
Q3 		– Sell
-2,929
Closed -$123K – 325
2017
Q2 		$123K Buy
+2,929
New +$150K 0.03% 281

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return